Related Experiment Videos
Participation of protease-activated receptor-1 in thrombin-induced microglial activation
Zhiming Suo1, Min Wu, Syed Ameenuddin
1Neurobiology Research Laboratory, Veterans Affairs Medical Center, Kansas City, Missouri 64128, USA. zsuo@kumc.edu
Abstract:
Activation of microglia, the resident macrophages in the CNS, plays a significant role in neuronal death or degeneration in a broad spectrum of CNS disorders. Recent studies indicate that nanomolar concentrations of the serine protease, thrombin, can activate microglia in culture. However, in contrast to other neural cells responsive to thrombin, the participation of novel protease-activated receptors (PARs), such as the prototypic thrombin receptor PAR1, in thrombin-induced microglial activation was cast in doubt. In this report, by utilizing primary microglial cultures from PAR1 knockout (PAR1-/-) mice, application of the PAR1 active peptide TRAP-6 (SFLLRN) in comparison to a scrambled peptide (LFLNR), we have unambiguously demonstrated that murine microglia constitutively express PAR1 mRNA that is translated into fully functional protein. Activation of the microglial PAR1 induces a rapid cytosolic free [Ca2+]i increase and transient activation of both p38 and p44/42 mitogen-activated protein kinases. Moreover, although in part, this PAR1 activation directly contributes to thrombin-induced microglial proliferation. Furthermore, although not directly inducing tumor necrosis factor-alpha (TNF-alpha) release, PAR1 activation up-regulates microglial CD40 expression and potentiates CD40 ligand-induced TNF-alpha production, thus indirectly contributing to microglial activation. Taken together, these results demonstrate an essential role of PAR1 in thrombin-induced microglial activation. In addition, strategies aimed at blocking thrombin signaling through PAR1 may be therapeutically valuable for diseases associated with cerebral vascular damage and significant inflammation with microglial activation.
Insights
Thrombin activates microglia, the brain's immune cells, via protease-activated receptor 1 (PAR1). Blocking PAR1 may offer therapeutic benefits for CNS disorders involving microglial activation and inflammation.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia activation contributes to neurodegeneration in CNS disorders.
- Thrombin activates microglia, but its receptor involvement was unclear.
- Protease-activated receptors (PARs) mediate cellular responses to proteases.
Purpose of the Study:
- To investigate the role of PAR1 in thrombin-induced microglial activation.
- To determine if microglia express functional PAR1.
- To elucidate downstream signaling pathways activated by PAR1 in microglia.
Main Methods:
- Primary microglial cultures from PAR1 knockout mice.
- Application of PAR1-activating peptide (TRAP-6) and scrambled peptide.
- Measurement of cytosolic calcium ([Ca2+]i) increase.
- Analysis of p38 and p44/42 mitogen-activated protein kinase (MAPK) activation.
- Assessment of CD40 expression and TNF-alpha production.
Main Results:
- Murine microglia express functional PAR1 mRNA and protein.
- PAR1 activation triggers [Ca2+]i increase and MAPK activation (p38, p44/42).
- PAR1 activation contributes to thrombin-induced microglial proliferation.
- PAR1 up-regulates CD40 expression and potentiates CD40 ligand-induced TNF-alpha production.
Conclusions:
- PAR1 plays an essential role in thrombin-induced microglial activation.
- PAR1 signaling contributes to microglial proliferation and inflammatory responses.
- Targeting PAR1 could be a therapeutic strategy for CNS disorders with microglial activation.